Our observation is further supported by the available literatures showing promising therapeutic efficacy exhibited by these lead molecules in in-vitro and in-vivo cancer model. Among the lead molecules Delphinidin 3,5-diglucoside, Baicalein, and Morphine have already been known for their anticancer properties, but the efficacy of Vitexin, IsoSkimmiwallin, Nodifloretin, Jaceosidin and Nepetin have not been explored so far and therefore further in-vitro and in-vivo study is warranted.